Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000095

EVP, Chf Clinical Develop Ofcr sold 1,413 shares at $40.67 ($57,464)

  • EVP, Chf Clinical Develop Ofcr acquired 4,033 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-03 Grant or award : show line 1 in the form +4,033 26,359 D
2023-02-06 Sale : show line 2 in the form −1,413 $40.67 $57,464 24,946 D
Open-market sales · 1,413 sh · avg $40.67 · $57,464
Loading xslF345X03/edgardoc.xml…